First patient-centered proton treatment room

IBA Group, a leader in advanced cancer diagnosis and therapy technologies, and Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced their first-ever installation of a state-of-the-art, patient-centered proton therapy treatment room in the United States.

Photo: First patient-centered proton treatment room
Photo: First patient-centered proton treatment room

A new addition to the Willis-Knighton Cancer Center in Shreveport, La., will be the first IBA installation to incorporate the Philips Ambient Experience.

Designed and engineered by Philips Healthcare, the Philips Ambient Experience promotes patient relaxation during proton treatments by permitting patients to selectively add comforting light, sound and images to the treatment room environment before they begin therapy. This will help improve the patient and staff experience, turning a cold, impersonal environment into one that comforts and reassures as the patient becomes an active participant in the process.

“This new installation is the first to come to fruition from the Philips-IBA cooperative agreement,” said Olivier Legrain, Chief Executive Officer at IBA. “It is demonstrative of a successful collaboration with Philips in offering highly advanced, patient-centered care, and we are delighted it will be integrated into our new proton system installations.”

“Ambient Experience enhances our ability to provide superior cancer care,” said Dr. Lane Rosen of the Willis-Knighton Cancer Center. “The soothing and empowering atmosphere will make our patients more comfortable, which will allow our staff to work more efficiently. IBA and Philips have been excellent partners, so it made sense to work with them to bring this unique experience to our patients.”

Willis-Knighton will be the first center to utilize Proteus®ONE, IBA’s single-room compact gantry solution for those looking for a more cost-effective, smaller footprint option. The $40 million project is expected to begin treating cancer patients with protons in early 2014.

Together with Philips, IBA is demonstrating a life-size model of the ProteusONE proton therapy room combined with the Philips Ambient Experience solution in booth #3019 at the 54th annual meeting of ASTRO, the American Society for Radiation Oncology, in Boston.

*Proteus®ONE is the brand name of a new configuration of the Proteus®235, including some new developments subject to review by Competent Authorities (FDA, European Notified Bodies, et al.) before marketing.

 

29.10.2012

Read all latest stories

Related articles

Photo

Article • Philips presents portfolio update at ECR 2022

AI-powered MRI to increase imaging speed, reduce staff burden

The portfolio Philips presented at ECR 2022 revealed that the company not only advanced their products, but also listened to medical professionals and patients – and took their feedback to heart.

Photo

Sponsored • Radiology collaboration

Improved workflow and a touch of Disney magic

Improving workflow is one of the major challenges that radiology departments face. The need to be more efficient, deliver timely and effective patient care, and keep an eye on costs are all factors…

Photo

Sponsored • Going digital

How digital pathology is shaping the future of precision medicine

In recent years, technological and regulatory advances have made digital pathology a viable alternative to the conventional microscope. The obtention of a digital replica of the traditional glass…

Related products

2-part PMMA CT-Phantom

Testing Devices

IBA Dosimetry · 2-part PMMA CT-Phantom

IBA Dosimetry GmbH
3-part PMMA CT-Phantom

Testing Devices

IBA Dosimetry · 3-part PMMA CT-Phantom

IBA Dosimetry GmbH
DIGI-13

Testing Devices

IBA Dosimetry · DIGI-13

IBA Dosimetry GmbH
Dosimax plus I

Testing Devices

IBA Dosimetry · Dosimax plus I

IBA Dosimetry GmbH
DSA Test Device

Testing Devices

IBA Dosimetry · DSA Test Device

IBA Dosimetry GmbH
DVT-3D

Testing Devices

IBA Dosimetry · DVT-3D

IBA Dosimetry GmbH
Subscribe to Newsletter